Company news
Cipher Pharmaceuticals Inc. news in 2017
Cipher Pharmaceuticals Inc.'s news releases, calls and decks from 2017, newest first.
Cipher Pharmaceuticals Announces New Credit Facility
November 3, 2017
Cipher Pharmaceuticals Reports Q3 2017 Operating & Financial Results
November 3, 2017
/C O R R E C T I O N from Source -- Cipher Pharmaceuticals Inc./
October 17, 2017
Cipher Pharmaceuticals Comments on Supply Chain Impact from Hurricane Maria
October 10, 2017
Cipher Pharmaceuticals Comments on FDA Warning Letter for ConZip® (Tramadol)
September 7, 2017
Cipher Pharmaceuticals reports Q2 2017 financial results
August 11, 2017
Notice of Cipher Pharmaceuticals Q2 2017 Conference Call
July 25, 2017
Cipher Pharmaceuticals Adds New Vice President of Corporate Development
June 2, 2017
Cipher Pharmaceuticals Reports Voting Results from Annual and Special Meeting of Shareholders
May 12, 2017
Cipher Pharmaceuticals reports Q1 2017 financial results
May 11, 2017
Cipher Pharmaceuticals Receives Health Canada Approval of OZANEX(TM) (ozenoxacin cream 1%)
May 8, 2017
Cipher Pharmaceuticals Announces Sale of U.S. Commercial Assets to EPI Group
May 1, 2017
Notice of Cipher Pharmaceuticals Q1 2017 Conference Call & Annual Meeting
April 27, 2017
Cipher Pharmaceuticals Proposes Adding Robert Tessarolo and Arthur Deboeck to Board of Directors
April 12, 2017
Cipher Pharmaceuticals announces amendment to debt agreement and partial prepayment
April 3, 2017
Cipher Pharmaceuticals Appoints Robert D. Tessarolo as CEO
March 20, 2017
Cipher Pharmaceuticals Reports 2016 Q4 & Year-End Financial Results
March 2, 2017
Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2016 Conference Call
February 16, 2017